The spectre of smallpox lingers - FDA last month approved the first ever drug to treat it. The disease officially exists in only two, highly secured places: the US CDC and its Russian counterpart, VECTOR. The greatest threat is advances in synthetic biology, where a rogue lab reengineers the virus.

The spectre of smallpox lingers - FDA last month approved the first ever drug to treat it. The disease officially exists in only two, highly secured places: the US CDC and its Russian counterpart, VECTOR. The greatest threat is advances in synthetic biology, where a rogue lab reengineers the virus.: https://ift.tt/2B5LsKX Read more... https://ift.tt/2vGSPUa